Injective
Financials
Estimates*
USD | 2022 | 2023 |
---|---|---|
Revenues | 4.5m | 6.6m |
% growth | - | 47 % |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$2.6m | Seed | ||
$10.0m | Series A | ||
* | $40.0m | Late VC | |
Total Funding | $52.6m |
Related Content
Recent News about Injective
EditInjective is a pioneering company in the decentralized finance (DeFi) space, offering a layer 2 decentralized exchange (DEX) protocol that enables the creation and trading of unlimited decentralized finance markets. The platform is designed to unlock the full potential of decentralized derivatives, providing a seamless and borderless trading experience. Injective serves a diverse range of clients, from novice traders to advanced financial professionals, who are looking to engage in decentralized derivatives, futures, perpetuals, and spot markets. Operating within the rapidly growing DeFi market, Injective leverages blockchain technology to ensure highly secure, instant, and frictionless transactions across various blockchain networks. The business model revolves around facilitating trades on its platform, earning revenue through transaction fees and staking services. Injective's user-friendly interface and advanced trading features make it a go-to platform for those seeking sophisticated and secure trading solutions in the DeFi space.
Keywords: decentralized exchange, DeFi, derivatives, blockchain, layer 2, perpetuals, futures, staking, cross-chain, secure transactions.